These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

81 related articles for article (PubMed ID: 16711249)

  • 1. [Modes for enhancing the efficiency of gadolinium chelates as contrast substances].
    Napolov IuK; Musatov SV
    Vestn Rentgenol Radiol; 2005; (1):58-62. PubMed ID: 16711249
    [No Abstract]   [Full Text] [Related]  

  • 2. Contrast-enhanced magnetic resonance cholangiography with Gd-BOPTA and Gd-EOB-DTPA in healthy subjects.
    Dahlström N; Persson A; Albiin N; Smedby O; Brismar TB
    Acta Radiol; 2007 May; 48(4):362-8. PubMed ID: 17453513
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Contrast-enhanced magnetic resonance imaging in the diagnosis of urinary tract disease].
    Shimanovskiĭ NL; Napolov IuK
    Vestn Rentgenol Radiol; 2005; (4):47-56. PubMed ID: 16353902
    [No Abstract]   [Full Text] [Related]  

  • 4. Intrathecal gadolinium-enhanced magnetic resonance myelography in the detection of CSF leak.
    Liong WC; Constantinescu CS; Jaspan T
    Neurology; 2006 Oct; 67(8):1522. PubMed ID: 17060599
    [No Abstract]   [Full Text] [Related]  

  • 5. Efficiency, thermodynamic and kinetic stability of marketed gadolinium chelates and their possible clinical consequences: a critical review.
    Port M; Idée JM; Medina C; Robic C; Sabatou M; Corot C
    Biometals; 2008 Aug; 21(4):469-90. PubMed ID: 18344005
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Contrast agent for intrathecal gadolinium administration.
    Albayram S; Gunduz A; Ozer H
    AJR Am J Roentgenol; 2006 Oct; 187(4):W446; author reply W447. PubMed ID: 16985121
    [No Abstract]   [Full Text] [Related]  

  • 7. [Gadolinium-DTPA tolerance and clinical safety].
    Niendorf HP; Brasch RC
    Rontgenpraxis; 1997 Dec; 50(12):354-63. PubMed ID: 9492559
    [No Abstract]   [Full Text] [Related]  

  • 8. [MR imaging of liver metastasis using Gd-EOB-DTPA].
    Kuwatsuru R
    Gan To Kagaku Ryoho; 2009 Aug; 36(8):1234-41. PubMed ID: 19692760
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Value of gadolinium in brain MRI examinations for developmental delay.
    Foerster BR; Ksar J; Petrou M; Eldevik PO; Maly PV; Carlson MD; Sundgren PC
    Pediatr Neurol; 2006 Aug; 35(2):126-30. PubMed ID: 16876010
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Low-dose gadobenate dimeglumine versus standard-dose gadopentate dimeglumine for delayed contrast-enhanced cardiac magnetic resonance imaging.
    Balci NC; Inan N; Anik Y; Erturk MS; Ural D; Demirci A
    Acad Radiol; 2006 Jul; 13(7):833-9. PubMed ID: 16777557
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In reference to 3 Tesla delayed contrast magnetic resonance imaging evaluation of Meniere's disease.
    Naganawa S; Nakashima T
    Laryngoscope; 2008 Oct; 118(10):1904-5; author reply 1905. PubMed ID: 18827624
    [No Abstract]   [Full Text] [Related]  

  • 12. [A new MR criterion in the diagnosis of capillary telangiectasis of the brain stem].
    Fellner FA; Frei J; Mölzer G
    Rofo; 2004 Dec; 176(12):1846-8. PubMed ID: 15573300
    [No Abstract]   [Full Text] [Related]  

  • 13. Reversible late gadolinium enhancement in a case of Takotsubo cardiomyopathy following high-dose dobutamine stress MRI.
    Bruder O; Hunold P; Jochims M; Waltering KU; Sabin GV; Barkhausen J
    Int J Cardiol; 2008 Jun; 127(1):e22-4. PubMed ID: 17467826
    [No Abstract]   [Full Text] [Related]  

  • 14. Delayed contrast enhancement magnetic resonance imaging for the assessment of cardiac disease.
    Marcu CB; Nijveldt R; Beek AM; Van Rossum AC
    Heart Lung Circ; 2007 Apr; 16(2):70-8. PubMed ID: 17317312
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intercellular imaging by a polyarginine derived cell penetrating peptide labeled magnetic resonance contrast agent, diethylenetriamine pentaacetic acid gadolinium.
    Guo YM; Liu M; Yang JL; Guo XJ; Wang SC; Duan XY; Wang P
    Chin Med J (Engl); 2007 Jan; 120(1):50-5. PubMed ID: 17254488
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The breast dynamic contrast enhanced MRI: preliminary results of a quantitative analysis.
    Di Nallo AM; Crecco M; Ortenzia O; Ordonez R; Abate A; Benassi M
    J Exp Clin Cancer Res; 2007 Jun; 26(2):235-9. PubMed ID: 17725104
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [What is late gadolinium enhancement in hypertrophic cardiomyopathy?].
    Moon JC
    Rev Esp Cardiol; 2007 Jan; 60(1):1-4. PubMed ID: 17288947
    [No Abstract]   [Full Text] [Related]  

  • 18. Liver vessel enhancement by Gd-BOPTA and Gd-EOB-DTPA: a comparison in healthy volunteers.
    Brismar TB; Dahlstrom N; Edsborg N; Persson A; Smedby O; Albiin N
    Acta Radiol; 2009 Sep; 50(7):709-15. PubMed ID: 19701821
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Breast magnetic resonance imaging: principles and techniques.
    Kaiser WA
    Semin Roentgenol; 2007 Oct; 42(4):228-35. PubMed ID: 17919525
    [No Abstract]   [Full Text] [Related]  

  • 20. Detection of brain metastases by magnetic resonance imaging: which magnetic resonance imaging sequence works best?
    Tikkakoski T
    Acta Radiol; 2008 Dec; 49(10):1097-8. PubMed ID: 18941952
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.